Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Korro Bio (KRRO) Net Cash Flow (2019 - 2025)

Korro Bio's Net Cash Flow history spans 7 years, with the latest figure at -$2.4 million for Q4 2025.

  • For the quarter ending Q4 2025, Net Cash Flow rose 74.21% year-over-year to -$2.4 million, compared with a TTM value of -$33.9 million through Dec 2025, up 70.3%, and an annual FY2025 reading of -$33.9 million, up 70.3% over the prior year.
  • Net Cash Flow for Q4 2025 was -$2.4 million at Korro Bio, up from -$9.5 million in the prior quarter.
  • The five-year high for Net Cash Flow was $121.8 million in Q4 2023, with the low at -$51.1 million in Q1 2021.
  • Average Net Cash Flow over 5 years is -$10.0 million, with a median of -$15.7 million recorded in 2023.
  • Year-over-year, Net Cash Flow plummeted 1202.96% in 2021 and then soared 1897.37% in 2023.
  • Tracing KRRO's Net Cash Flow over 5 years: stood at -$32.4 million in 2021, then skyrocketed by 79.1% to -$6.8 million in 2022, then soared by 1897.37% to $121.8 million in 2023, then tumbled by 107.66% to -$9.3 million in 2024, then surged by 74.21% to -$2.4 million in 2025.
  • Per Business Quant, the three most recent readings for KRRO's Net Cash Flow are -$2.4 million (Q4 2025), -$9.5 million (Q3 2025), and -$30.5 million (Q2 2025).